2QZ-19800-12368
5 vaccinations
8 coded responses
65 check-ins
7 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 972 / OR
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Pfizer-BioNTech
- 2021-03-13
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: Injection site discomfort — Feeling: Good · Fatigue or tirednessFree text: Mild soreness at injection site but not painfulMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-27
-
2021-04-03
Dose 2 — Pfizer-BioNTech
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Peripheral coldness — Feeling: Fair · Headache, Fatigue or tirednessFree text: Cold toes last night; had to wear socksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
-
2021-04-10
Survey response — day 7, dose 2MedDRA: Unevaluable event — Feeling: Good · HeadacheFree text: At night while in bed. Likely unrelated to vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-07-03
- 2021-10-02
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-26
-
2021-11-02
Survey response — day 28, dose 3MedDRA: Abdominal discomfort, Asthenia, Diarrhoea, Flushing, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Episode of intense stomach and intestinal discomfort with diarrhea, brief nausea, flushing and intense weakness that subsided quickly with sensitive stomach and weakness lasting a couple of days.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-09
- 2021-11-16
- 2022-01-04
- 2022-04-05
-
2022-04-08
Dose 4 — Moderna
-
2022-04-08
Survey response — day 0, dose 4MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-04-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-10
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain — Feeling: GoodFree text: Slight soreness at injection locationMedDRA releases: 2024-11 · check-in free text available
- 2022-04-11
- 2022-04-12
- 2022-04-13
- 2022-04-14
- 2022-04-15
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-07-08
-
2022-09-08
Dose 5 — Pfizer-BioNTech
-
2022-09-09
Survey response — days 1–6 daily, dose 5MedDRA: Injection site pain — Feeling: Fair · Fatigue or tirednessFree text: Slight soreness when injection site pressedMedDRA releases: 2024-11 · check-in free text available
- 2022-09-10
- 2022-09-11
- 2022-09-12
- 2022-09-13
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-12-08
-
2023-03-09
Survey response — 6 months, dose 5MedDRA: Nasal congestion, Pyrexia, SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Moderna | No |
| 5 | 2022-09-08 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Mild soreness at injection site but not painful
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Cold toes last night; had to wear socks
Release 7 — day 7, dose 2
Systemic reaction (other): At night while in bed. Likely unrelated to vaccine
Release 10 — day 28, dose 3
Symptoms: Episode of intense stomach and intestinal discomfort with diarrhea, brief nausea, flushing and intense weakness that subsided quickly with sensitive stomach and weakness lasting a couple of days.
Release 11 — day 0, dose 4
Systemic reaction (other): No
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Slight soreness at injection location
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Slight soreness when injection site pressed
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Flushing | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Peripheral coldness | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release